On February 1, 2023, the FTC announced a proposed $1.5 million settlement with GoodRx Holdings, based on alleged violations of the Federal Trade Commission Act (“FTC Act”) and Health Breach Notification Rule (“HBNR”) for using advertising technologies on its websites and mobile app that resulted in the unauthorized disclosure of consumers’ personal and health information to advertisers and other third parties. On the same day, the U.S. Department of Justice, acting on behalf of the FTC, filed a Complaint and Proposed Stipulated Order detailing the FTC’s allegations and the terms of the proposed settlement.
Blog Editors
Recent Updates
- Video: Employment Law in 2026: What to Expect - Employment Law This Week
- When Your Data Sets Your Price: New York Takes on Algorithmic Pricing
- Artificial Intelligence Regulation at a Crossroads: The Trump Administration’s Preemption Push
- Your AI in HR Must-Do List: Navigating Illinois’ Draft AI Notice Regulations
- Video: Top Employment Law Changes of 2025 - Employment Law This Week